Item Details

Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program, 1992-1998 [electronic resource]: United States

United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
Format
Computer Resource; Online; Dataset
Published
Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2001
Edition
2008-10-23
Series
ICPSR
ICPSR (Series)
Access Restriction
AVAILABLE. This study is freely available to the general public.
Abstract
The purpose of the Cooperative Agreement (CA) Research Program was to monitor risk factors, risk behaviors, and rates of HIV seroprevalence and seroincidence among out-of-treatment, multi-ethnic/racial injection drug users and crack cocaine users. The program evaluated the efficacy of experimental interventions designed to prevent, eliminate, or reduce HIV risk behaviors and developed new treatment interventions. All participants received the standard intervention, which consisted of street-based outreach and HIV prevention counseling. Those assigned to enhanced interventions received more counseling sessions, educational videos, social gatherings, and support group activities. The public-use data file contains 31,088 respondent records, collected from 21 CA program facilities in the United States and one facility each in Puerto Rico and Brazil. Hence, the process data file contains 23 records of facility information that can be linked to individual respondents. Respondent interviews include a baseline Risk Behavior Assessment (completed prior to first intervention) and a Follow-Up Assessment, conducted either three months or six months after the baseline survey. Respondent data were augmented with eligibility information, biological markers of drug use, HIV test results, and intervention assignment. At baseline and post-intervention, the surveys measured drug use and drug treatment, sexual activity and sex for money/drugs, arrests, work/income, HIV/STD/pregnancy status, perceptions of risk, and risk reduction behaviors. The process questionnaires were completed by staff or principal investigators at the 23 site locations. Process data describe the program structure and process, other intervention projects in the community, needle exchange programs and pharmacy syringe sales, and local HIV infection rates. Drugs reported on include alcohol, marijuana/hashish, crack/cocaine, heroin (including speedball), non-prescription methadone, other opiates, and amphetamines.Cf: http://doi.org/10.3886/ICPSR03023.v1
Contents
  • Respondent Data
  • Process Data
Description
Mode of access: Intranet.
Notes
Title from ICPSR DDI metadata of 2016-02-11.
Series Statement
ICPSR 3023
ICPSR (Series) 3023
Other Forms
Also available as downloadable files.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 04441cmm a2200541la 4500
    001 ICPSR03023
    003 MiAaI
    006 m f a u
    007 cr mn mmmmuuuu
    008 160211s2001 miu f a eng d
    035
      
      
    a| (MiAaI)ICPSR03023
    040
      
      
    a| MiAaI c| MiAaI
    245
    0
    0
    a| Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program, 1992-1998 h| [electronic resource] b| [United States] c| United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
    250
      
      
    a| 2008-10-23
    260
      
      
    a| Ann Arbor, Mich. b| Inter-university Consortium for Political and Social Research [distributor] c| 2001
    490
      
      
    a| ICPSR v| 3023
    516
      
      
    a| Numeric
    538
      
      
    a| Mode of access: Intranet.
    500
      
      
    a| Title from ICPSR DDI metadata of 2016-02-11.
    536
      
      
    a| United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse c| N01DA-6-5052
    506
      
      
    a| AVAILABLE. This study is freely available to the general public.
    530
      
      
    a| Also available as downloadable files.
    522
      
      
    a| United States
    520
    3
      
    a| The purpose of the Cooperative Agreement (CA) Research Program was to monitor risk factors, risk behaviors, and rates of HIV seroprevalence and seroincidence among out-of-treatment, multi-ethnic/racial injection drug users and crack cocaine users. The program evaluated the efficacy of experimental interventions designed to prevent, eliminate, or reduce HIV risk behaviors and developed new treatment interventions. All participants received the standard intervention, which consisted of street-based outreach and HIV prevention counseling. Those assigned to enhanced interventions received more counseling sessions, educational videos, social gatherings, and support group activities. The public-use data file contains 31,088 respondent records, collected from 21 CA program facilities in the United States and one facility each in Puerto Rico and Brazil. Hence, the process data file contains 23 records of facility information that can be linked to individual respondents. Respondent interviews include a baseline Risk Behavior Assessment (completed prior to first intervention) and a Follow-Up Assessment, conducted either three months or six months after the baseline survey. Respondent data were augmented with eligibility information, biological markers of drug use, HIV test results, and intervention assignment. At baseline and post-intervention, the surveys measured drug use and drug treatment, sexual activity and sex for money/drugs, arrests, work/income, HIV/STD/pregnancy status, perceptions of risk, and risk reduction behaviors. The process questionnaires were completed by staff or principal investigators at the 23 site locations. Process data describe the program structure and process, other intervention projects in the community, needle exchange programs and pharmacy syringe sales, and local HIV infection rates. Drugs reported on include alcohol, marijuana/hashish, crack/cocaine, heroin (including speedball), non-prescription methadone, other opiates, and amphetamines.Cf: http://doi.org/10.3886/ICPSR03023.v1
    505
      
      
    t| Respondent Data
    505
      
      
    t| Process Data
    567
      
      
    a| Multi-ethnic/racial male and female drug injectors and crack users at risk for HIV in the United States.
    650
      
    7
    a| AIDS 2| icpsr
    650
      
    7
    a| counseling 2| icpsr
    650
      
    7
    a| drug abuse 2| icpsr
    650
      
    7
    a| drug education 2| icpsr
    650
      
    7
    a| drug offenders 2| icpsr
    650
      
    7
    a| health education 2| icpsr
    650
      
    7
    a| HIV 2| icpsr
    650
      
    7
    a| intervention 2| icpsr
    650
      
    7
    a| outreach programs 2| icpsr
    650
      
    7
    a| race 2| icpsr
    650
      
    7
    a| risk assessment 2| icpsr
    650
      
    7
    a| risk factors 2| icpsr
    650
      
    7
    a| treatment 2| icpsr
    653
    0
      
    a| SAMHDA XVI. Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program
    653
    0
      
    a| NAHDAP I. National Addiction and HIV Data Archive Program
    653
    0
      
    a| ICPSR XVI.A. Social Indicators, United States
    653
    0
      
    a| RCMD V. Health and Well-Being
    710
    2
      
    a| United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
    710
    2
      
    a| Inter-university Consortium for Political and Social Research.
    830
      
    0
    a| ICPSR (Series) v| 3023
    856
    4
    0
    u| http://proxy01.its.virginia.edu/login?url=http://doi.org/10.3886/ICPSR03023.v1
    999
      
      
    w| WEB l| INTERNET m| UVA-LIB t| INTERNET

Availability

Access Online